
Remi Meds Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 5.6/10
Best for: per-dose-tier compounded GLP-1 with named Strive Pharmacy partner
Remi Meds scores below our bar on medical oversight. Read the score breakdown before signing up.
Semaglutide
Tirzepatide
Price checked on Remi Meds' site,
What the monthly price covers
Medication
Included
Provider visits
Not stated
Shipping
Not stated
Lab work
Not stated
Coaching
Not stated
No insurance needed · Vetted by our editors
Remi Meds is a DTC compounded-GLP-1 telehealth platform offering per-dose-tier compounded semaglutide and tirzepatide-with-B12, plus NAD+, Sermorelin, and Glutathione add-ons. It names its pharmacy partner (Strive Pharmacy, Gilbert, AZ) and clinical network (Beluga Health), and surfaces full per-tier pricing rather than a floor-only "as low as." Semaglutide runs $249–$369/mo and tirzepatide $349–$639/mo. (Distinct from Remedy Meds.)
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money
Vetted alternatives to Remi Meds
Ro
Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help
Editorial score · methodology
Collective
Best for: the lowest flat medication price if you can absorb an annual membership fee
Editorial score · methodology
CoreAge Rx
Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose
Editorial score · methodology
Remi Meds at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $249/mo (starting dose)
- Pricing model
- Scales with dose: higher doses cost more
- What's included
- Medication
- FDA status
- No FDA warning letter on record
How we scored Remi Meds
Each dimension is scored algorithmically from Remi Meds'published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.
Value25%
4.9/10Remi Meds' headline is $249 a month at the starting dose. Compare it with other programs on the same plan basis. Note the price scales with dose, so budget for higher tiers as you titrate.
Effectiveness25%
6.8/10Remi Meds offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
5.8/10Online intake and platform experience; 7 platform features disclosed.
Trust & Safety15%
5.9/10Core details confirmed by our editors; no FDA warning letters on file.
Accessibility10%
4.7/10Remi Meds' exact state footprint isn't published. Confirm coverage in your state before signing up.
Support10%
4.5/10Remi Meds provides standard clinician follow-up; no extended coaching or community program is disclosed.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Remi Meds review
Last checked October 2026- Confirmed current pricing across 4 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the provider's public sign-up flow, stopping before payment
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: medium.
What we checked
- Provider's own pricing page
- $249–$639/mo across 4 dose/plan tiers (checked October 2026)
- State pharmacy licensing & LegitScript status
- LegitScript Verified
- FDA warning-letter register
- No letter on file for this provider
What to expect when you sign up with Remi Meds
We walked Remi Meds' public signup flow in October 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Open a treatment page (Personalized GLP-1 or GLP-1/GIP + B12) or the Book Now page.
- 2Pick a dose from the price dropdown.
- 3Click Start My Free Visit, which opens a 4-step questionnaire.
- 4Step 1 asks for your name, sex, date of birth, email and phone.
- Full per-dose pricing is shown before intake: semaglutide $249-$369/mo, tirzepatide + B12 $349-$639/mo.
- The visit is advertised as free; you pay for medication only if prescribed.
- Refills aren't auto-charged: you get a monthly renewal notice and pay only if you continue.
- Submitted orders can't be changed or canceled, and shipped prescriptions are final sale.
- Some states require a live video or chat visit, plus a photo ID and selfie.
- Three different phone numbers appear across the site.
Remi Meds customer support
- Phone
- (888) 782-6101
- hello@remimeds.com
GLP-1 medications Remi Meds offers
Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.
Peptides Remi Meds offers
Beyond GLP-1s, Remi Meds also offers these peptides. Tap any for our evidence-based guide.
Pricing
Prices re-verified
$249/mo at 0.25mg. Other tiers: 0.5mg $289, 1mg $329, 1.7mg $345, 2.4mg $369 per month.
$349/mo at 2.25mg. Other tiers: 4.5mg $379, 6.75mg $429, 9mg $549, 11.25mg $639 per month.
Ready to get started?
Plans and promotions change often, so check Remi Meds' current pricing and active discounts before you decide.
What we like
- Names its compounding pharmacy (Strive Pharmacy, Gilbert AZ), which most peers don't do
- LegitScript certification badge on the homepage
- Publishes 503A FDCA compliance language on the tirzepatide page
- Per-dose-tier pricing fully shown, not just an 'as low as' floor
- Operating corporate entity disclosed (T-C Health Co)
- Does not sell retatrutide, in line with current FDA enforcement
- Clear non-affiliation disclaimer for Wegovy/Ozempic/Mounjaro trademarks
Watch-outs
- No named medical director, founder, or physician on any public page
- States served not listed; the FAQ only says 'nationwide service'
- Clinical care runs via Beluga Health, a network a 2026 StatNews analysis tied to many FDA-warned GLP-1 sellers (Remi itself isn't warned)
- Orders can't be changed or canceled once submitted, and shipped prescriptions are final sale
- Three different phone numbers and a secondary 'Rekindle RX' email hint at shared infrastructure
- Mailing address (Leesburg FL) doesn't match the operating-entity state (California)
- The free-visit form asks for your name, date of birth, email and phone on the first screen
Remi Meds: a transparent price list with a thin paper trail on the people behind it
Remi Meds is a direct-pay, compounded-only GLP-1 telehealth shop that does two things most of its competitors won't. It names the pharmacy that fills your prescription. And it publishes its full per-dose price ladder instead of teasing you with a single 'as low as' floor. That candor is useful when you're shopping. The same site that's upfront about pricing, though, stays quiet about who its medical leadership is, so you are weighing one strong form of transparency against a notable gap in another. If you value seeing the price for the exact dose you'll be on, Remi Meds is worth considering. If you want a named medical director and a clear corporate history, you'll want to read the cautions below first.
How the pricing works: five tiers that climb with your dose
Remi Meds uses a scales-with-dose model, which is a transparent way to price compounded GLP-1s and also the one that can surprise you later. You don't pay one flat rate. Your monthly cost rises as your dose is titrated up. Compounded semaglutide starts at $249 a month at the 0.25 mg starting dose and steps up to the high-three-hundreds at the 2.4 mg maintenance dose. Compounded tirzepatide, which Remi Meds bundles with B12, opens in the mid-three-hundreds and climbs to the low-six-hundreds at the top maintenance tier.
Budget for where you'll end up, not where you start. The starting-dose price is accurate, but most people titrate upward over a few months, and you will spend most of your time in the maintenance tiers. Even so, the entry semaglutide rate sits above the category median of $179 a month, so Remi Meds competes on showing you the whole ladder before you commit rather than on being the cheapest. There's no published teaser or first-month promo rate, so the tiered list is what you pay.
How we get the market median: $179 is the middle value of each program's lowest listed ongoing monthly price for compounded semaglutide (month to month, not a first-month promo, a prepaid plan or a price with a membership on top), across the 129 programs that publish one.
The medications and who fills them
Remi Meds sells compounded medication only, with no brand-name Wegovy, Ozempic, Mounjaro or Zepbound, and Remi Meds is careful to post a non-affiliation disclaimer for those trademarks. You get compounded semaglutide and compounded tirzepatide-with-B12 as the core offerings, with NAD+, Sermorelin and Glutathione available as add-ons if you're after the broader wellness menu.
Remi Meds tells you the medication is filled by Strive Pharmacy in Gilbert, Arizona, a specific compounding pharmacy you can look up instead of an anonymous 'licensed partner.' Most compounded-GLP-1 sellers won't give you that name. Pair that with the §503A FDCA compliance language on the tirzepatide page and a LegitScript badge on the homepage, and you have more of a traceable supply chain than the average direct-pay compounder offers.
No retatrutide on the menu
The site does not sell retatrutide, the experimental triple-agonist that the FDA moved against in September 2025. Plenty of compounding sellers kept pushing it anyway. A provider that declines to stock a molecule regulators are actively warning about is showing the kind of restraint you want from a company handling prescription injectables. It's a green flag in an industry that has plenty of red ones.
What gives us pause
For all its pricing candor, Remi Meds is opaque about who runs your care. No medical director, founder, or physician is named anywhere on the public site. By contrast, Spry puts its three co-founders' names on the page and asks for no contract, though it also shows an 'FDA Approved' badge that doesn't apply to compounded drugs. The states it serves aren't listed; the site makes a blanket 'nationwide' claim with no per-state detail. And the corporate footprint is a little mismatched. The operating entity is T-C Health Co, organized in California, but the mailing address is in Leesburg, Florida. A secondary 'Rekindle RX' email and three different phone numbers across the site hint at shared back-office infrastructure that isn't explained.
- No named clinician or leadership: you can't see who's overseeing your care or running the company.
- Clinical care runs through Beluga Health, a physician network a 2026 StatNews analysis tied to a large share of FDA-warned GLP-1 telehealth companies. Remi Meds itself has no FDA warning letter, but you should know about the network-level association.
- Direct-pay only: no insurance is accepted, and shipped prescriptions are final sale, so there's no money-back cushion if it isn't a fit. A submitted order can't be changed or canceled either. Refills aren't auto-charged, though: you get a monthly renewal notice and pay only if you continue.
- Year founded and corporate history are unclear, which makes it hard to judge track record.
Trust and safety: solid on paper, thin on people
Remi Meds clears several safety bars. The pharmacy is named. The LegitScript badge is present. The §503A language is posted. And there's no FDA warning letter against Remi Meds or T-C Health Co. Don't confuse this company with Remedy Meds, a separate brand that did receive an FDA warning letter. Remi Meds is a different corporate entity with a clean letter record. Still, the missing medical leadership, the unenumerated state list, and the Beluga network association keep it out of the top tier. Our scoring methodology weighs disclosed oversight heavily, and that's where Remi Meds loses points.
Who should choose Remi Meds, and who should skip it
Choose it if you're a confident self-pay shopper who wants to see the per-dose price up front, values knowing the filling pharmacy by name, and prefers a seller that steers clear of the molecules regulators are chasing. Skip it if you need insurance billing, want a named physician or medical director you can vet, require a clear list of the states served before you'll enter payment details, or want any refund protection beyond 'all sales final.'
Bottom line
Remi Meds is a better-than-average compounded-GLP-1 platform on the dimensions it chooses to be transparent about (pricing, pharmacy, and regulatory restraint) and noticeably thin on the ones it doesn't: named medical oversight and corporate clarity. The full price ladder and the Strive Pharmacy disclosure give you reasons to pick it over a floor-only competitor. Just go in clear-eyed: confirm the dose you'll ultimately need (and its price), accept that there's no insurance path or refund, and decide whether a platform with no named clinician meets your bar for a long-term medication you'll inject every week. Patients who want a fuller workup first can look at Tonik Wellness, which requires lab work and a provider call before prescribing. Its catch is a three-month minimum on every plan.
The Bottom Line
Remi Meds scores below our bar on medical oversight. Read the score breakdown before signing up.
Ready to start with Remi Meds?
From $249 a month at the starting dose. See current pricing and start your online intake.
Remi Meds might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Head-to-head
Compare Remi Meds vs…
Remi Meds scores5.6/10
Side-by-side pricing, medications and scores. Pick a matchup.
Remi Meds vs Amazon One Medical
Amazon One Medical scores 8.5/10

Remi Meds vs Vytora Health
Vytora Health scores 8.4/10
Scores are our independent editorial ratings out of 10.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Remi Meds review:
Sources & methodology (as of November 2026)
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 4.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Remi Meds' current pricing
Plans from $249 a month at the starting dose. Start the online intake to check eligibility and today's price.